ETF Managers Group, LLC Esperion Therapeutics, Inc. Transaction History

ETF Managers Group, LLC

  • $2.78 Billion
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$11.34 - $21.37 $226,754 - $427,314
-19,996 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$19.4 - $28.71 $124,489 - $184,232
6,417 Added 47.26%
19,996 $423,000
Q1 2021

May 17, 2021
BUY
$25.12 - $36.89 $341,104 - $500,929
13,579 New
13,579 $373,000

Others Institutions Holding ESPR

# of Institutions
211
Shares Held
129M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $124M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email